OTCMKTS:AVDX - Avant Diagnostics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0320 0.00 (0.00 %) (As of 05/9/2019)Previous Close$0.0320Today's Range$0.0320 - $0.032052-Week Range$0.0001 - $0.0784Volume38,501 shsAverage Volume4,936 shsMarket Capitalization$10.78 millionP/E RatioN/ADividend YieldN/ABeta9.42 ProfileChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Avant Diagnostics, Inc., a commercial-stage molecular data-generating company, focuses on the development and commercialization of proprietary data-generating assays that provide information for physicians and patients in the areas of cancers. It owns license and distribution right for OvaDx, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. The company was founded in 2009 and is based in Washington, District of Columbia. Receive AVDX News and Ratings via Email Sign-up to receive the latest news and ratings for AVDX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AVDX Previous Symbol CUSIPN/A CIKN/A Webavantdiagnostics.com Phone708-710-9200Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$250,000.00 Price / Sales43.13 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book3.20Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,370,000.00 Net MarginsN/A Return on Equity-143.01% Return on Assets-51.41%Miscellaneous Employees2 Outstanding Shares336,960,000Market Cap$10.78 million Next Earnings DateN/A OptionableNot Optionable Avant Diagnostics (OTCMKTS:AVDX) Frequently Asked Questions What is Avant Diagnostics' stock symbol? Avant Diagnostics trades on the OTCMKTS under the ticker symbol "AVDX." Has Avant Diagnostics been receiving favorable news coverage? Press coverage about AVDX stock has trended somewhat positive this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avant Diagnostics earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Avant Diagnostics' key competitors? Some companies that are related to Avant Diagnostics include Biocept (BIOC), CBA Florida (CBAI), First Choice Healthcare Solutions (FCHS), Cancer Genetics (CGIX), OpGen (OPGN), Aeon Global Health (AGHC) and Foundation Medicine (FMI). What other stocks do shareholders of Avant Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avant Diagnostics investors own include Bottomline Technologies (EPAY), SYSCO (SYY), American Airlines Group (AAL), American Railcar Industries (ARII), Cray (CRAY), GW Pharmaceuticals PLC- (GWPH), Netflix (NFLX), Extraction Oil & Gas (XOG), Boeing (BA) and BankUnited (BKU). Who are Avant Diagnostics' key executives? Avant Diagnostics' management team includes the folowing people: Mr. Jeffrey M. Busch, Exec. Chairman (Age 59)Dr. Michael I. Ruxin, Pres, CEO & Director (Age 73)Mr. Scott VanderMeer, Interim Chief Financial Officer (Age 32)Dr. Glenn D. Hoke Ph.D., Chief Scientific OfficerMs. Rene A. Schena, Chairman & CEO of Arrayit Corp. (Age 56) How do I buy shares of Avant Diagnostics? Shares of AVDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Avant Diagnostics' stock price today? One share of AVDX stock can currently be purchased for approximately $0.0320. How big of a company is Avant Diagnostics? Avant Diagnostics has a market capitalization of $10.78 million and generates $250,000.00 in revenue each year. Avant Diagnostics employs 2 workers across the globe. What is Avant Diagnostics' official website? The official website for Avant Diagnostics is avantdiagnostics.com. How can I contact Avant Diagnostics? Avant Diagnostics' mailing address is 1050 30TH STREET NW SUITE 107, WASHINGTON DC, 20007. The company can be reached via phone at 708-710-9200 or via email at [email protected] MarketBeat Community Rating for Avant Diagnostics (OTCMKTS AVDX)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 40 (Vote Outperform)Underperform Votes: 59 (Vote Underperform)Total Votes: 99MarketBeat's community ratings are surveys of what our community members think about Avant Diagnostics and other stocks. Vote "Outperform" if you believe AVDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVDX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Outstanding Shares, Buying and Selling Stocks Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.